{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:58:13Z","timestamp":1773982693864,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd004481","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T00:00:00Z","timestamp":1082332800000}}],"reference-count":98,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004481.pub2","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T11:14:09Z","timestamp":1082718849000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Colchicine for primary biliary cirrhosis"],"prefix":"10.1002","volume":"2010","author":[{"given":"Yan","family":"Gong","sequence":"first","affiliation":[{"name":"Bispeberg Bakke 26C, 2.th Copenhagen NV Denmark 2400"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,4,19]]},"reference":[{"key":"10.1002\/14651858.CD004481.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1046\/j.1365-2036.2000.00869.x","article-title":"Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis","volume":"14","author":"Almasio","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4 Pt. 2","key":"10.1002\/14651858.CD004481.pub2-BIB0002|cit2","first-page":"267A","article-title":"The Italian multi-centre randomized controlled trial of ursodeoxycholic acid vs. ursodeoxycholic acid plus colchicne in symtomatic primary biliary cirrhosis. (AASLD abstract)","volume":"20","author":"Almasio","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1046\/j.1365-2036.2001.01018.x","article-title":"Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients","volume":"15","author":"Battezzati","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0004|cit4","unstructured":"Podda M Almasio P Battezzati PM Crosignani A and the Italian multicenter group for the study of UDCA in PBC Long-term effect of the administration of ursodeoxycholic acid alone or with colchicine in patients with primary biliary cirrhosis: a double-blind multicentre study Bile Acids and the Hepatobiliary System: From Basic Science to Clinical Practise. Falk Symposium 68 Dordrecht\/Boston\/London Kluwer Academic Publishers 1993 310 5"},{"issue":"5","key":"10.1002\/14651858.CD004481.pub2-BIB0005|cit5","first-page":"968","article-title":"A randomised double-blind controlled trial of colchicine in primary biliary cirrhosis (AASLD abstract)","volume":"5","author":"Bodenheimer","year":"1985","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004481.pub2-BIB0006|cit6","first-page":"1172","article-title":"Colchicine therapy in primary biliary cirrhosis (AASLD abstract)","volume":"6","author":"Bodenheimer","year":"1986","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0016-5085(88)90300-9","article-title":"Evaluation of colchicine therapy in primary biliary cirrhosis (see comments)","volume":"95","author":"Bodenheimer","year":"1988","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD004481.pub2-BIB0008|cit8","first-page":"990","article-title":"Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy","volume":"14","author":"Zifroni","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0009|cit9","first-page":"151A","article-title":"A trial of ursodeoxycholic acid (UDCA) and colchicine in primary biliary cirrhosis (PBC) (AASLD abstract)","volume":"20","author":"Goddard","year":"1994","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD004481.pub2-BIB0010|cit10","first-page":"A30","article-title":"Surrogate markers of response in a trial of ursodeoxycholic acid (UDCA) and colchicine in primary biliary cirrhosis (PBC) (abstract)","volume":"36","author":"Goddard","year":"1995","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD004481.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0168-8278(96)80191-7","article-title":"Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study","volume":"24","author":"Ikeda","year":"1996","journal-title":"Journal of Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD004481.pub2-BIB0012|cit12","first-page":"1127","article-title":"Histocompatibility antigens in primary biliary cirrhosis","volume":"82","author":"Johnston","year":"1987","journal-title":"The American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD004481.pub2-BIB0013|cit13","first-page":"967","article-title":"Colchicine is effective in the treatment of primary biliary cirrhosis (AASLD abstract)","volume":"5","author":"Kaplan","year":"1985","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD004481.pub2-BIB0014|cit14","first-page":"382","article-title":"A prospective trial of colchicine for primary bilairy cirrhosis. (abstract)","volume":"50","author":"Kaplan","year":"1987","journal-title":"Acta Gastroenterologica Belgica"},{"issue":"23","key":"10.1002\/14651858.CD004481.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198612043152304","article-title":"A prospective trial of colchicine for primary biliary cirrhosis","volume":"315","author":"Kaplan","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004481.pub2-BIB0016|cit16","first-page":"465","article-title":"Serum interleukin-2 and tumor necrosis factor-alpha in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4","volume":"87","author":"Miller","year":"1992","journal-title":"The American Journal of Gastroenterology"},{"issue":"4 Pt. 2","key":"10.1002\/14651858.CD004481.pub2-BIB0017|cit17","first-page":"176A","article-title":"Double-blind trial of methotrexate (MTX) versus colchicine (COLCH) in primary biliary cirrhosis (PBC) (AASLD abstract)","volume":"18","author":"Kaplan","year":"1993","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004481.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0016-5085(99)70403-8","article-title":"A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis","volume":"117","author":"Kaplan","year":"1999","journal-title":"Gastroenterology"},{"issue":"4 Pt. 2","key":"10.1002\/14651858.CD004481.pub2-BIB0019|cit19","first-page":"152A","article-title":"Methotrexate (MTX) improves histology in primary biliary cirrhosis (PBC) (AASLD abstract)","volume":"20","author":"Kaplan","year":"1994","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD004481.pub2-BIB0020|cit20","first-page":"518","article-title":"Synthesis of Interleukin-1beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchcine and disease progression","volume":"22","author":"Miller","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0016-5085(94)90085-X","article-title":"Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis","volume":"107","author":"Sharma","year":"1994","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD004481.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1572-0241.2003.07182.x","article-title":"Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate","volume":"98","author":"Young-Mee","year":"2003","journal-title":"The American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD004481.pub2-BIB0023|cit23","first-page":"I","article-title":"The combination of ursodeoxycholic acid (UDCA) and colchicine (C) for patients with primary biliary cirrhosis (PBC): effect on hepatic function and portal hypertension (IASL abstract)","volume":"23","author":"Huet","year":"1996","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004481.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.510240520","article-title":"A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis","volume":"24","author":"Poupon","year":"1996","journal-title":"Hepatology"},{"issue":"4 Pt. 2","key":"10.1002\/14651858.CD004481.pub2-BIB0025|cit25","first-page":"151A","article-title":"A randomised trail comparing the combination ursodeoxycholic acid (UDCA) and colchicine to UDCA alone in primary biliary cirrhosis (AASLD abstract)","volume":"20","author":"Poupon","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0026|cit26","unstructured":"Raedsch R Stiehl A Walker S Rudi J Schlenker T Gerteis C Controlled study on the effects of a combined ursodeoxycholic acid plus colchicine treatment in primary biliary cirrhosis Bile acids and the hepatology system: From basic science to clinical practice. Falk Symposium 68 Dordrecht\/Boston\/London Kluwer Academic Publishers 1993 303 9"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD004481.pub2-BIB0027|cit27","first-page":"55","article-title":"Ursodeoxycholic acid plus colchicine treatment in primary biliary cirrhosis: a controlled double-blind pilot study (Germany)","volume":"30","author":"Raedsch","year":"1992","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0028|cit28","unstructured":"Raedsch R Stiehl A Walker S Theilmann L Kommerell Effects of ursodeoxycholic acid and ursodeoxycholic acid plus colchicine im primary biliary cirrhosis: a double-blind pilot study Bile acids and the hepatology system: From basic science to clinical practice. Falk Symposium 58 Dordrecht\/Boston\/London Kluwer Academic Publishers 1991 310 4"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00196579","article-title":"Ursodeoxycholic acid treatment lowers the serum levels of antibodies against pyrovate dehydrogenase and influences their inhibitory capacity for the enzme complex in patients with primary biliary cirrhosis","volume":"74","author":"Kisand","year":"1996","journal-title":"Journal of Molecular Medicine"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1699-0463.1998.tb00235.x","article-title":"Antibodies to pyruvate dehydrogenase in primary biliary cirrhosis: correlation with histology","volume":"106","author":"Kisand","year":"1998","journal-title":"APMIS"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0032|cit31","first-page":"A954","article-title":"Improvement of serum noncholesterol sterols may indicate retarded progression of primary biliary cirrhosis (PBC) in a randomized placebo controlled two-year trial with colchicine and ursodeoxycholic acid (AASLD abstract)","volume":"104","author":"Miettinen","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0031|cit32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/0270-9139(95)90046-2","article-title":"Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine","volume":"21","author":"Miettinen","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0168-8278(97)80293-0","article-title":"Expression and therapeutic response related to apolipoprotein E polymorphism in primary biliary cirrhosis","volume":"27","author":"Vuoristo","year":"1997","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0016-5085(95)90696-7","article-title":"A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid [see comments]","volume":"108","author":"Vuoristo","year":"1995","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004481.pub2-BIB0035|cit35","first-page":"S348","article-title":"A controlled trial of colchicine in primary biliary cirrhosis (PBC) (EASL abstract)","volume":"1","author":"Warnes","year":"1985","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004481.pub2-BIB0036|cit36","first-page":"1022","article-title":"A controlled trial of colchicine in primary biliary cirrhosis (AASLD abstract)","volume":"4","author":"Warnes","year":"1984","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD004481.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(87)80053-3","article-title":"A controlled trial of colchicine in primary biliary cirrhosis: trial design and preliminary report","volume":"5","author":"Warnes","year":"1987","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD004481.pub2-BIB0038|cit38","first-page":"I","article-title":"Liver function and prognosis in primary biliary cirrhosis: \"sharp\" and \"blunt\" tests and the influence of colchicine treatment on survival (IASL abstract)","volume":"23","author":"Warnes","year":"1996","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD004481.pub2-BIB0039|cit39","first-page":"420","article-title":"Progression of primary biliary cirrhosis (PBC) with and without colchicine therapy (IASL abstract)","volume":"12","author":"Klion","year":"1990","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0040|cit40","first-page":"1309","article-title":"Treatment of primary biliary cirrhosis with colchicine (abstract)","volume":"78","author":"Koldinger","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1440-1746.1992.tb00980.x","article-title":"Combination therapy with ursodeoxycholic acid and colchicine for primary biliary cirrhosis","volume":"7","author":"Shibata","year":"1992","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004481.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00005792-199409000-00005","article-title":"Primary biliary cirrhosis (classical article)","volume":"73","author":"Ahrens","year":"1994","journal-title":"Medicine-Baltimore"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Intereaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study","volume":"98","author":"Balasubramaniam","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(84)91108-5","article-title":"Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis","volume":"ii","author":"Ballardini","year":"1984","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1046\/j.1365-2036.2001.01018.x","article-title":"Ten-year combination treatment with colchicine and ursodeoxycholic acid for priamry biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients","volume":"15","author":"Battezzati","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD004481.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0048|cit48","doi-asserted-by":"crossref","unstructured":"Ben-Chetrit E Levy M Colchicine: 1998 update Seminars in Arthritis and Rheumatism 1998 48 59","DOI":"10.1016\/S0049-0172(98)80028-0"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0016-5085(85)90325-7","article-title":"Asymptomatic primary biliary cirrhosis: a progress report on long-term follow-up and natural history","volume":"89","author":"Beswick","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD004481.pub2-BIB0051|cit51","article-title":"Cochrane Reviewers' Handbook 4.2.0 [updated March 2003]","author":"Clarke","year":"2003","journal-title":"The Cochrane Libary"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods of combining randomized clinical trials: strengths and limitaions","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/newbio238257a0","article-title":"Microtubules in transcellular movement of procollagen","volume":"238","author":"Ehrlich","year":"1972","journal-title":"Nature New Biology"},{"issue":"8233","key":"10.1002\/14651858.CD004481.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(81)92456-9","article-title":"D-penicillamine treatment improves survival in primary biliary cirrhosis","volume":"1","author":"Epstein","year":"1981","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004481.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0016-5085(82)80125-X","article-title":"The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"83","author":"Epstein","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0059|cit59","first-page":"A1121","article-title":"Antimitochondrial antibodies AMA of primary biliary cirrhosis PBC recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha ketoacid dehydrogenase complex","volume":"3","author":"Fregeau","year":"1989","journal-title":"Faseb-Journal"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0168-8278(98)80301-2","article-title":"'Negative trials' are positive! (Invited Editorial)","volume":"28","author":"Gluud","year":"1998","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD004481.pub2-BIB0061|cit61","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","author":"Gluud","year":"2002","journal-title":"The Cochrane Library"},{"issue":"4","key":"10.1002\/14651858.CD004481.pub2-BIB0062|cit62","article-title":"Colchicine for primary biliary cirrhosis","author":"Gong","year":"2003","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/art.1780140602","article-title":"Effects of colchicine on collagenase in cultures of rheumatoid synovium","volume":"14","author":"Harris","year":"1971","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0016-5085(76)80250-8","article-title":"A prospective controlled trial of azathioprine in primary biliary cirrhosis","volume":"70","author":"Heathcote","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis","volume":"91","author":"Hoofnagle","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0066|cit66","volume-title":"Code of Federal Regulation & ICH Guidelines","author":"International Conference on Harmonisation of Technical Requiements for Registration of Pharmaceuticals for Human Use","year":"1997"},{"issue":"5","key":"10.1002\/14651858.CD004481.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD004481.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1073\/pnas.98.3.831","article-title":"Evolution of treatment effects over time: empirical insigh from recursive cumulative metaanalyses","volume":"98","author":"Ioannidis","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0069|cit69","first-page":"1278","article-title":"Primary biliary cirrhosis-a revised clinical spectrum","volume":"i","author":"James","year":"1981","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0016-5085(91)90085-Y","article-title":"Treatment of primary biliary cirrhosis with low-dose weekly methotrexate","volume":"101","author":"Kaplan","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM199405123301912","article-title":"Primary biliary cirrhosis - a first step in prolonging survival","volume":"330","author":"Kaplan","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD004481.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004481.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-1007191","article-title":"The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis","volume":"17","author":"Kaplan","year":"1997","journal-title":"Seminars in Liver Diseases"},{"issue":"11","key":"10.1002\/14651858.CD004481.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004481.pub2-BIB0075|cit75","first-page":"247","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis","volume":"90","author":"Lacerda","year":"1995","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0076|cit76","unstructured":"Liberati A D'Amico R Torri V Tinazzi A Leonetti C Pifferi S Meta-analyses from different source of information Proceedings of The 4th International Cochrane Colloquium; 1996 Oct. 21-24; North Terrace Adelaide 1996"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0077|cit77","first-page":"1158","article-title":"The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study","volume":"22","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7326\/0003-4819-30-1-121","article-title":"Xanthomatous biliary cirrhosis (a clinical syndrome)","volume":"30","author":"MacMahon","year":"1949","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004481.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM198202113060602","article-title":"A prospective trial of D-penicillamine in primary biliary cirrhosis","volume":"306","author":"Matloff","year":"1982","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004481.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in health adults","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis: three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD004481.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis","volume":"26","author":"Neuberger","year":"1985","journal-title":"Gut"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365528909092240","article-title":"Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease","volume":"24","author":"Nyberg","year":"1989","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(99)80098-1","article-title":"Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis","volume":"30","author":"Poupon","year":"1999","journal-title":"Jounal of Hepatology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD004481.pub2-BIB0088|cit88","first-page":"171A","article-title":"Symptom development and prognosis of initially asymptomatic PBC","volume":"32","author":"Prince","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD004481.pub2-BIB0089|cit89","article-title":"Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis (Cochrane Review)","author":"Rambaldi","year":"2003","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/003591576706001205","article-title":"Primary biliary cirrhosis","volume":"40","author":"Scheuer","year":"1967","journal-title":"Proceedings of the Royal Society of Medicine"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD004481.pub2-BIB0092|cit92","first-page":"219","article-title":"Recent progress in the development of tubulin inhibitors as antimitotic antitumor agents","volume":"4","author":"Shi","year":"1998","journal-title":"Current Pharmaceutical Design"},{"issue":"1","key":"10.1002\/14651858.CD004481.pub2-BIB0093|cit93","first-page":"124","article-title":"A study of antimitochondrial antibodies in a random population in Estonia","volume":"92","author":"Turchany","year":"1997","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD004481.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0168-8278(86)80483-4","article-title":"Expression of MHC products by normal and abnormal bile duct epithelium","volume":"3","author":"Oord","year":"1986","journal-title":"Journal of Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD004481.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00042737-199908000-00001","article-title":"Prescribing habits in primary biliary cirrhosis: a national survey","volume":"11","author":"Verma","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"20","key":"10.1002\/14651858.CD004481.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004481.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.1840060309","article-title":"Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis","volume":"6","author":"Yamada","year":"1986","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004481.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1572-0241.2005.41522.x","article-title":"Colchicine for primary biliary cirrhosis: a Cochrane Hepato-Biliary Group Systematic Review of randomized clinical trials","volume":"100","author":"Gong","year":"2005","journal-title":"American Journal of Gastroenterology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004481.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:19:52Z","timestamp":1761149992000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004481.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2004,4,19]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004481.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,19]]}}}